Floatz logo

Bacitracin

Inflammatory Bowel Disease (IBD)

Assistance Publique - Hôpitaux de ParismixturePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Inflammatory Bowel Disease (IBD) cohort.

Asset / SponsorPhaseRating
NEOMYCIN
Assistance Publique - Hôpitaux de Paris
Phase 2B
Colon Kcc Heptapeptide
Danielle Kim Turgeon
Phase 1CC

Same molecule, other indications

Bacitracin is also rated in:

skin carcinomaDormant
B
Indicative ·
57 / 100
View asset →
Primary Sclerosing Cholangitis (PSC)Dormant
CCC
Indicative ·
53 / 100
View asset →
Breast CancerDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →